GNB infection in hospital -> NEJM 2010-5大整理 -> 使用anti-guidelines

Hospital-Acquired Infections Caused by Gram-Negative Bacteria

A review of a major healthcare challenge

Hospital-acquired infections contribute substantially to rising healthcare costs as well as in-hospital morbidity and mortality. Nosocomial infections caused by gram-negative organisms are a major concern, as these organisms account for more than 30% of hospital-acquired infections and 70% of infections in the intensive care unit.

Gram-negative bacteria have proven particularly adept at developing novel resistance mechanisms, and they employ a variety of resistance strategies. In this review, the authors detail the microbiology, resistance patterns, management strategies, and treatment recommendations for three commonly encountered hospital-acquired infections: pneumonia, bacteremia, and urinary tract infections. In each of these conditions, infections caused by gram-negative organisms, especially pseudomonas, Acinetobacter, and the Enterobacteriaceae family, predominate.

Interventions performed in the hospital, such as mechanical ventilation and insertion of venous and urinary catheters, place patients at risk for developing infections. Rising antibiotic resistance (particularly to extended-spectrum cephalosporins and carbapenems) coupled with severe disease that often is associated with gram-negative infections means that initial management should include broad-spectrum antibiotic coverage (Table 1). For empirical treatment of patients with severe infections, combination therapy ("double coverage") is recommended, with tailoring of antibiotic choice based on local susceptibility data; de-escalation to monotherapy is recommended once susceptibilities are determined. Novel treatment strategies — including continuous infusions of antibiotics, aerosolized antibiotics, and newer antibiotics — might be of benefit, but clinical experience and definitive studies are lacking.

Following evidence-based prevention guidelines is paramount to preventing hospital-acquired infections. Simple activities, such as hand hygiene and sterile techniques, and efforts to minimize patient exposure can lower risk for nosocomial infections (Table 2). Adherence to prevention guidelines is essential if we are to stem the rising tide of hospital-acquired infections.

— Robin Klein, MD

Dr. Klein is an Assistant Professor at Emory University School of Medicine in Atlanta, Georgia.

Published in Journal Watch Hospital Medicine June 7, 2010

Citation(s):

Peleg AY and Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010 May 13; 362:1804.


裏面有risk factors, 強力用藥指引，相當強大
和目前本院用藥相合
但combination 多很多

有VAP bundle, CVP bundle, UTI bundle

http://docs.google.com/fileview?id=0B278nGJMQBk7MGMzMDIwNzAtNDNhMS00Y2RlLTkxYWEtMGI0ZWY2NGM4YmRk&hl=en

留言

張貼留言

這個網誌中的熱門文章

即便是用IGRA, 有時也要等大於三個月才能決定TB contact

圖片
接觸TB後，TST大抵上2-12週轉陽，IGRA大抵上6-10週，但IGRA可以長到3個月以上 TB Tests Can Have a Lengthy Window Period Two studies suggest that interferon- release assay conversion sometimes occurs more than 3 months after exposure to active tuberculosis. Increasingly, interferon- release assays (IGRAs) are being used for diagnosing latent tuberculosis (TB). Although the tuberculin skin test (TST) traditionally used for this purpose converts to positive within 2 to 12 weeks after an individual is exposed to someone with active TB, the interval for IGRA conversion has remained unclear. Current guidelines recommend repeating an initially negative IGRA after 6 to 10 weeks, but this recommendation is not based on controlled studies. Two recent investigations address this issue. Anibarro and colleagues conducted a longitudinal prospective analysis among contacts of TB patients in Spain. The 152 contacts received a TST and an IGRA at first visit; for individuals with negative or conflicting results, t
閱讀完整內容

白宮為了掌控醫療費用，傾向大型醫療，個體戶勢必受挫

所以一旦政府介入，中外醫療提供者都傾向大型化…… independent practice -> dreaming 診所評鑑??應該擋住! http://www.medscape.com/viewarticle/727420 Physicians Say White House Should Not Write Off Small Practices August 24, 2010 — In a newly published article, the White House is advising physicians to accept a life in Big Medicine — as a hospital employee or member of a large group practice — in the wake of healthcare reform. Some leaders of organized medicine, however, are objecting to the government message. "We're not ready to write off the small practices," J. Fred Ralston Jr, MD, president of the American College of Physicians, told Medscape Medical News. "We think there needs to be more than one delivery model." "America is not a one-size-fits-all country," added M. Todd Williamson, MD, a neurologist from Lawrenceville, Georgia, and spokesperson for a coalition of medical societies opposed to the new healthcare reform law, now called the Affordable Care Act. Dr. Ralston and Dr.
閱讀完整內容

老美接受LTBI treatment的人，不到一半完治，和duration成正比

This study shows that although acceptance of LTBI treatment is relatively high (83%), the proportion completing is low (47%). When the product of these two proportions is calculated, we see that completion was achieved by only 39% of persons who were offered LTBI treatment. The major risk factor for noncompletion was being prescribed the 9-month INH regimen. As shown in Figure 1, when the proportions completing the three most commonly prescribed regimens are compared, it can be seen that there is an inverse relationship between length of the regimen prescribed and the proportion completing treatment. The increased completion that we observed with the 4-month rifampin regimen is consistent with previous reports.[18–20] It is of interest to note that if completion of the 9-month regimen were defined as completion of at least 6 months of INH, the noncompletion rate of the 9-month regimen, 42.9%, would have been almost identical to that of the 6-month regimen, 44.8%. Thus, prescribing the
閱讀完整內容